Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

DowDuPont’s (DWDP) Raised to Buy

The current recommendation of Buy for DowDuPont Inc (NULL:DWDP) has been derived by using Louis Navellier's methodology for investing and his Portfolio Grader stock evaluator. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Verizon (VZ) a Hold on Pallid Earnings Visibility

Portfolio Grader currently ranks Verizon Communication Inc (NYSE:VZ) a Hold. With unique fundamental and quantitative analytical tools developed by Louis Navellier, this analytical tool assesses nearly 5,000 stocks weekly. VZ has maintained this ranking for 3 months.

Novartis AG (NVS) a Buy on Solid Earnings Visibility

Novartis AG (NYSE:NVS) is classified as a constituent of the 133 company Pharmaceuticals GICS industry group, which is a segment of the 781 company GICS Health Care sector. NVS has a market value of $195.5 billion which is in the top 10% of its industry group. Currently, the stock's Portfolio Grader ranking places it 23 among the 133 companies in this industry group, putting in the top quartile; in the top quartile of the sector with a ranking of 166 among the 781 companies in the sector, and number 1,096 in the nearly 5,000 company Portfolio Grader universe.

Sagging Earnings Visibility Drops China Mobile (CHL) to Hold

Portfolio Grader currently ranks China Mobile Ltd (NYSE:CHL) a Hold. The methodology for fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier assesses and ranks nearly 5,000 stocks each week. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Improving Earnings Growth Analytics Drive Upgrade of Pfizer (PFE) to Buy

Pfizer Inc (NYSE:PFE) is one of 133 companies within the Pharmaceuticals GICS industry group, which is in turn part of the 781 company GICS Health Care sector. PFE has a market value of $210.8 billion which is in the top 10% of its industry group. The ranking for PFE by Portfolio Grader places it 35 among the 133 companies in this industry group, placing it in the top half; in the top half of the sector with a ranking of 206 among the 781 companies in the sector, and number 1,335 in the nearly 5,000 company Portfolio Grader universe.

AT&T (T) a Sell on Flagging Earnings Visibility

AT&T Inc (NYSE:T) is a $211.9 billion in market value component of the Diversified Telecommunication Services GICS industry group where the stock's Portfolio Grader ranking currently places it 37 among the 45 companies in this industry group, a spot that is well below-average. T is ranked squarely in the bottom quartile of the sector with a ranking of 54 among the 66 companies in the sector and number 3,611 in the 5000 company Portfolio Grader company universe.

Chevron (CVX) a Buy on Solid Sales Growth

Currently, Chevron Corp (NYSE:CVX) has a Buy using Louis Navellier's methodology for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking CVX has had from Portfolio Grader for 4 months.

Quant Score Hamper Exxon Mobil (XOM) Rating

With a $340.0 billion market value, Exxon Mobil Corp (NYSE:XOM) ranks in the top decile in its industry group, Oil Gas & Consumable Fuels, and in the top decile of sector group, Energy, in market value. From the prospective of investment attractiveness, The current Portfolio Grader ranking for XOM puts it 157 among the 290 companies in this industry group, which is a below-average position; in the top half of the sector with a ranking of 181 among the 363 companies in the sector, and number 2,717 in the nearly 5,000 company Portfolio Grader universe.

Johnson & Johnson (JNJ) a Buy on Strong Quant Score

Currently, Johnson & Johnson Co (NYSE:JNJ) has a Buy using the methodology for investing of Louis Navellier and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 8 months.

Flopping Earnings Visibility Make Quality Systems (QSII) a Sell

Currently, Quality Systems Inc (NASDAQ:QSII) has a Sell using the approach of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for the last month.

Quant Score Analytics Keep HMS Holdings (HMSY) a Strong Sell

With a $1.4 billion market value, HMS Holdings Corp (NASDAQ:HMSY) ranks in the top half of its industry group, Health Care Technology, and in the upper half of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the stock's current Portfolio Grader ranking places it 24 among the 24 companies in this industry group, a position that is well below-average; squarely in the bottom quartile of the sector with a ranking of 717 among the 781 companies in the sector, and number 4,305 in the nearly 5,000 company Portfolio Grader universe.

Omnicell (OMCL) a Buy on Healthy Earnings Momentum

Omnicell Inc (NASDAQ:OMCL) is a $1.8 billion in market value constituent of the Health Care Technology GICS industry group where Portfolio Grader's current ranking for OMCL puts it 3 among the 24 companies in this industry group, giving it a well above-average position. OMCL is ranked in the top quartile of the sector with a ranking of 81 among the 781 companies in the sector and number 474 in the 5000 company Portfolio Grader company universe.

Inovalon Holding (INOV) a Hold on Vapid Sales Growth

Inovalon Holding Inc (NASDAQ:INOV) is ranked as a Hold using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing system. INOV has maintained this ranking for 3 months.

Quant Score Metrics Restrict Allscripts Healthcare Solutions (MDRX) Ratings Upgrade to Hold

Allscripts Healthcare Solutions (NASDAQ:MDRX) is ranked as a Hold using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. MDRX has been upgraded from a Sell to a Hold in the last week.

Cotiviti Holdings (COTV) Earnings Momentum Limit Rating

Currently, Cotiviti Holdings Inc (NYSE:COTV) has a Hold using the approach to investing of Louis Navellier and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 2 months.

Industry Group Rank Restrict Medidata Solutions (MDSO) Rating

The current recommendation of Hold for Medidata Solutions (NASDAQ:MDSO) has been derived by using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking MDSO has had from Portfolio Grader for 3 months.

athenahealth (ATHN) a Buy on Superior Earnings Momentum

athenahealth Inc (NASDAQ:ATHN) is ranked as a Buy using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing system. This represents no change from the previous week and is the same ranking ATHN has had from Portfolio Grader for the last month.

Icon (ICLR) Raised to Strong Buy from a Buy

Icon Plc (NASDAQ:ICLR) ranks in the upper half of its industry group, Life Sciences Tools & Services, and in the top 25% of its sector group, Health Care, with a market value of $6.3 billion. From an investment attractiveness vantage point, ICLR is ranked in the top decile of the sector with a ranking of 31 among the 781 companies in the sector; the stock's Portfolio Grader ranking places it 4 among the 32 companies in this industry group, putting in the top quartile and number 191 in the 5000 company Portfolio Grader company universe.

Vapid Quant Score Hurt Qiagen NV (QGEN) Rating

Currently, Qiagen NV (NASDAQ:QGEN) has a Hold using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methodology. QGEN has recently seen its Portfolio Grader rating downgraded over the last month from a Buy to a Hold.